Abstract:Despite tremendous advances in neonatal intensive care over the past 20 years, prematurity carries a high burden of neurological morbidity lasting lifelong. The term encephalopathy of prematurity (EoP) coined by Volpe in 2009 encompasses all aspects of the now known effects of prematurity on the immature brain, including altered and disturbed development as well as specific lesional hallmarks. Understanding the way cells are damaged is crucial to design brain protective strategies, and in this purpose, preclinical models largely contribute to improve the comprehension of the cell death mechanisms. While neuronal cell death has been deeply investigated and characterized in (hypoxic–ischemic) encephalopathy of the newborn at term, little is known about the types of cell death occurring in preterm brain injury. Three main different morphological cell death types are observed in the immature brain, specifically in models of hypoxic–ischemic encephalopathy, namely, necrotic, apoptotic, and autophagic cell death. Features of all three types may be present in the same dying neuron. In preterm brain injury, description of cell death types is sparse, and cell loss primarily concerns immature oligodendrocytes and, infrequently, neurons. In the present review, we first shortly discuss the different main severe preterm brain injury conditions that have been reported to involve cell death, including periventricular leucomalacia (PVL), diffuse white matter injury (dWMI), and intraventricular hemorrhages, as well as potentially harmful iatrogenic conditions linked to premature birth (anesthesia and caffeine therapy). Then, we present an overview of current evidence concerning cell death in both clinical human tissue data and preclinical models by focusing on studies investigating the presence of cell death allowing discriminating between the types of cell death involved. We conclude that, to improve brain protective strategies, not only apoptosis but also other cell death (such as regulated necrotic and autophagic) pathways now need to be investigated together in order to consider all cell death mechanisms involved in the pathogenesis of preterm brain damage.

The Regulated Cell Death and Potential Interventions in Preterm Infants after Intracerebral Hemorrhage

Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models

Neuroprotective Therapies for Spontaneous Intracerebral Hemorrhage

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

Brain Damage in the Preterm Infant: Clinical Aspects and Recent Progress in the Prevention and Treatment

Preventing Brain Injury in the Preterm Infant—Current Controversies and Potential Therapies

Hypothermia and temperature modulation for intracerebral hemorrhage (ICH): pathophysiology and translational applications

Pharmacological neuroprotection and clinical trials of novel therapies for neonatal peri-intraventricular hemorrhage: a comprehensive review

Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhage

Modes of Brain Cell Death Following Intracerebral Hemorrhage

Regulated cell death in hypoxic-ischaemic encephalopathy: recent development and mechanistic overview

Neuroprotective strategies for neonatal hypoxic-ischemic brain damage: Current status and challenges

Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage.

Treatment of Intracerebral Hemorrhage: Current Approaches and Future Directions

Preterm Brain Injury: Mechanisms and Challenges

Umbilical cord blood cells for the treatment of preterm white matter injury: Potential effects and treatment options

Role of Regulatory T Cells in Intracerebral Hemorrhage

Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation

Mechanism of Ferroptosis and Its Relationships With Other Types of Programmed Cell Death: Insights for Potential Interventions After Intracerebral Hemorrhage

Mechanisms and potential therapeutic targets for spontaneous intracerebral hemorrhage

Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage